| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.063 | 0.03 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.11 | 0.04 |